POSTER - The 88th EAS Congress

POSTER

Switch To Module

Conference Calendar
POSTER
Authors

GENERAL SEARCH
Title
Poster Number
Author
Presenter

Filter By

Select AllDeselect All
1. PATHOGENESIS OF ATHEROSCLEROSIS / 1.1 Endothelial cell function and biology21
1. PATHOGENESIS OF ATHEROSCLEROSIS / 1.2 Smooth muscle cell biology1
1. PATHOGENESIS OF ATHEROSCLEROSIS / 1.3 Macrophages in lipid metabolism and atherosclerosis6
1. PATHOGENESIS OF ATHEROSCLEROSIS / 1.4 Inflammation, immunity and infection in atherosclerosis31
1. PATHOGENESIS OF ATHEROSCLEROSIS / 1.5 Extracellular matrix and calcification5
1. PATHOGENESIS OF ATHEROSCLEROSIS / 1.6 Hormones and atherosclerosis6
1. PATHOGENESIS OF ATHEROSCLEROSIS / 1.7 Vascular biology of the arterial wall: Miscellaneous15
1. PATHOGENESIS OF ATHEROSCLEROSIS / 1.8 Atherosclerosis regression14
1. PATHOGENESIS OF ATHEROSCLEROSIS / 1.9 Imaging technology2
2. LIPIDS AND LIPOPROTEINS / 2.1 Lp(a)16
2. LIPIDS AND LIPOPROTEINS / 2.10 Modified lipoproteins6
2. LIPIDS AND LIPOPROTEINS / 2.2 TG rich lipoproteins metabolism and lipases6
2. LIPIDS AND LIPOPROTEINS / 2.3 HDL11
2. LIPIDS AND LIPOPROTEINS / 2.4 Lipoprotein receptors1
2. LIPIDS AND LIPOPROTEINS / 2.5 Bile acids3
2. LIPIDS AND LIPOPROTEINS / 2.6 Cholesterol efflux and reverse cholesterol transport5
2. LIPIDS AND LIPOPROTEINS / 2.7Lipids beyond cholesterol and triglycerides (lipidomics)8
2. LIPIDS AND LIPOPROTEINS / 2.8 Cellular lipid metabolism and lipid droplets6
2. LIPIDS AND LIPOPROTEINS / 2.9 Lipid and lipoprotein metabolism: Miscellaneous20
3. DYSLIPIDEMIA AND RISK FACTORS / 3.1 Epidemiology of cardiovascular diseases and risk factors57
3. DYSLIPIDEMIA AND RISK FACTORS / 3.10 Coagulation1
3. DYSLIPIDEMIA AND RISK FACTORS / 3.11 Gut microbiome2
3. DYSLIPIDEMIA AND RISK FACTORS / 3.12 Gene editing technology3
3. DYSLIPIDEMIA AND RISK FACTORS / 3.13 Genomics, GWAS and population genetics; Mendelian randomization12
3. DYSLIPIDEMIA AND RISK FACTORS / 3.14 Epigenetics and microRNA3
3. DYSLIPIDEMIA AND RISK FACTORS / 3.15 Gene-Environment interactions3
3. DYSLIPIDEMIA AND RISK FACTORS / 3.2 Epidemiology of dyslipidemias20
3. DYSLIPIDEMIA AND RISK FACTORS / 3.3 Diabetes, insulin sensitivity and resistance17
3. DYSLIPIDEMIA AND RISK FACTORS / 3.4 Adipose tissue homeostasis4
3. DYSLIPIDEMIA AND RISK FACTORS / 3.5 Inherited dyslipidemias35
3. DYSLIPIDEMIA AND RISK FACTORS / 3.6 Gender and cardiovascular risk12
3. DYSLIPIDEMIA AND RISK FACTORS / 3.7 Environmental risk factors6
3. DYSLIPIDEMIA AND RISK FACTORS / 3.8 Novel risk factors and biomarkers35
3. DYSLIPIDEMIA AND RISK FACTORS / 3.9 Epidemiology of socioeconomic and psychosocial risk factors4
4. CLINICAL VASCULAR DISEASE / 4.1 Coagulation and Thrombosis4
4. CLINICAL VASCULAR DISEASE / 4.10 Anti-thrombotic therapies2
4. CLINICAL VASCULAR DISEASE / 4.11 Anti-inflammatory therapies2
4. CLINICAL VASCULAR DISEASE / 4.12 Prevention and treatment of cardiovasculardisease; miscellaneous70
4. CLINICAL VASCULAR DISEASE / 4.13 New lipid lowering therapies4
4. CLINICAL VASCULAR DISEASE / 4.2 Endothelial dysfunction; Clinical assessment10
4. CLINICAL VASCULAR DISEASE / 4.3 NASH and other ectopic lipid diseases5
4. CLINICAL VASCULAR DISEASE / 4.4 Chronic kidney disease and nephropathies8
4. CLINICAL VASCULAR DISEASE / 4.5 Diabetes; macro- and microangiopathies13
4. CLINICAL VASCULAR DISEASE / 4.6 Aneurysms and other non-atherosclerotic arteriopathies6
4. CLINICAL VASCULAR DISEASE / 4.7 Nutrition, nutraceuticals7
4. CLINICAL VASCULAR DISEASE / 4.8 Bariatric surgery1
4. CLINICAL VASCULAR DISEASE / 4.9 Lipid-lowering therapies22
SaaG e-Posters: Adipose tissue biology and obesity6
SaaG e-Posters: Atherogenic lipoproteins: on prognostics and mechanisms4
SaaG e-Posters: Cellular lipid metabolism and lipid droplets7
SaaG e-Posters: Coagulation and thrombosis5
SaaG e-Posters: Coronary interventions and gastric bypass: outcome determinants5
SaaG e-Posters: Diabetes, lipid metabolism, and inflammation4
SaaG e-Posters: Diabetes: new mechanisms and life-style interventions1
SaaG e-Posters: Diet and nutrition: what should we have?4
SaaG e-Posters: Endothelial function and arterial stiffness from a clinical standpoint5
SaaG e-Posters: Extracellular matrix and calcification in the development of atherosclerosis5
SaaG e-Posters: Familial chylomicronemia and dysbetalipoproteinemias7
SaaG e-Posters: Fatty liver - how to get rid of?5
SaaG e-Posters: FH and the life-long disease burden7
SaaG e-Posters: Focus on endothelial cell biology6
SaaG e-Posters: Focus on inflammation and immunity4
SaaG e-Posters: Genetics on lipoproteins, cognition, DM2 and Alzheimer’s10
SaaG e-Posters: HDL - rise and shine?4
SaaG e-Posters: Hot spots in clinical imaging2
SaaG e-Posters: How to protect the kidneys?5
SaaG e-Posters: Hypertension, arterial calcification, and cardiovascular disease4
SaaG e-Posters: Improving risk estimation: lessons from coagulation, thrombosis, and miRNAs5
SaaG e-Posters: Improving risk estimation: population studies, proteomics, ceramides and extracellular vesicles5
SaaG e-Posters: Inflammation and immunity: clinical research6
SaaG e-Posters: Inflammation, immunity and vascular biology in clinical studies4
SaaG e-Posters: Key elements of endothelial cell function5
SaaG e-Posters: Learn the latest on Lp(a)6
SaaG e-Posters: Life-style, gender disparity, and psychosocial risk factors in CVD1
SaaG e-Posters: Linking immunity, inflammation and lipid metabolism in atherosclerosis6
SaaG e-Posters: Lipid-lowering therapies4
SaaG e-Posters: Macrophages at the crossroads of lipid and inflammatory pathways5
SaaG e-Posters: Modified lipoproteins, receptors, and bile acids3
SaaG e-Posters: New lipid-lowering therapies and advances with the current ones5
SaaG e-Posters: Novel findings in vascular biology4
SaaG e-Posters: Novel risk factors, biomarkers, and anti-inflammatory therapies4
SaaG e-Posters: Novel targets to regulate smooth muscle cells5
SaaG e-Posters: Peripheral artery disease and ischemic stroke5
SaaG e-Posters: Reaching treatment goals and optimising compliance7
SaaG e-Posters: Removing cholesterol: efflux and reverse cholesterol transport5
SaaG e-Posters: Screening for and characterising FH4
SaaG e-Posters: Smooth muscle cells and vascular remodelling5
SaaG e-Posters: Statin and anti-PCSK9 therapies4
SaaG e-Posters: The double-edged sword of inflammation and immunity5
SaaG e-Posters: The latest on FH genetics5
SaaG e-Posters: Treatment response in FH7
SaaG e-Posters: Triglycerides and lipases5
SaaG e-Posters: Vascular disease in diabetes4
SaaG e-Posters: What’s hot in vascular biology?6

Bookmarks
Sign in

Poster Grouping

1 ePoster
Session Name
SaaG e-Posters: Life-style, gender disparity, and psychosocial risk factors in CVD
Filtered By

View

Gallery
List

4. CLINICAL VASCULAR DISEASE || 4.12 Prevention and treatment of cardiovasculardisease; miscellaneous

SaaG e-Posters: Life-style, gender disparity, and psychosocial risk factors in CVD

234 - Siesta and healthy aging in older Mediterranean people: the MEDIS epidemiological study (ID 531)

Only SaaG posters should upload a MP3 file in this step.

Session Name

SaaG e-Posters: Life-style, gender disparity, and psychosocial risk factors in CVD

Presentation Topic

4.12 Prevention and treatment of cardiovasculardisease; miscellaneous

Presenter

Alexandra Foscolou, Greece

Authors

Alexandra Foscolou, Greece
Stefanos Tyrovolas, Greece
Antonia-Leda Matalas, Greece
Evangelos Polychronopoulos, Greece
Loukianos Rallidis, Greece
Labros S. Sidossis, United States of America
Demosthenes Panagiotakos, Greece

Programme and Faculty are preliminary and subject to change.
Give Feedback
© 2019 cSLIDE CTI MEETING TECHNOLOGY. All rights reserved.

Please add your email also in the body of the message in order to get a reply